Forensic scientists use postmortem imaging-guided biopsy to determine natural causes of death

Oct 21, 2010

Researchers found that the combination of computed tomography (CT), postmortem CT angiography (CTA) and biopsy can serve as a minimally invasive option for determining natural causes of death such as cardiac arrest, according to a study in the November issue of the American Journal of Roentgenology.

In the last decade, postmortem imaging, especially CT, has gained increasing acceptance in the forensic field. However, CT has certain limitations in the assessment of natural death.

"Vascular and organ pathologic abnormalities, for example, generally cannot be visualized accurately using native CT scans. To address the problem of these abnormalities, postmortem angiography has been implemented with great success," said Stephan A. Bolliger, MD, lead author of the study.

Researchers from the Institute of Forensic Medicine, Centre for Forensic Imaging and Virtopsy, at the University of Bern in Bern, Switzerland, examined 20 bodies in a minimally invasive fashion using CT, CTA and biopsy and compared the results to those obtained at subsequent autopsy. Results showed that the minimally invasive examination showed almost identical results in 18 of 20 cases.

"The combination of CT, postmortem CTA and is a valid tool to examine bodies in a minimally invasive fashion. However, a close collaboration between pathologists and radiologists is imperative for the correct sampling and diagnostic assessment and, therefore, for the success of such an undertaking," said Bolliger.

Explore further: AMA: Gender inequality still exists in medicine

More information: www.ajronline.org/

Provided by American College of Radiology

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.